There are several interesting diagnostics companies in the Nordic region. Nordic success within diagnostics might be explained by the right business strategy, high qualitative research and cross-disciplinary and cross-boundary collaborations.
Other advantages for the development of diagnostics are our extensive biobanks and patient registers as well as our civic registration unique ID numbers. Drug companies and diagnostic test developers are also increasingly teaming up to produce theranostics, diagnostic therapy for individual patients, taking advantage of these strengths.
Related articles:
Mercodia has found its own course
Improved prognosis, treatment and drug discovery
Aiming for visible difference
Profile - Magnus Lundberg, CEO Phadia
Who is responsible for diagnosis?
